menu
    • menu

    Company profile for Theravia

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    THERAVIA stands as a premier global pharmaceutical entity focusing on rare or overlooked diseases. Arising from the merger of Addmedica and CTRS, our commitment lies in tackling the unaddressed medical requirements of patients grappling with these complex conditions. Possessing an intimate grasp of the distinct hurdles confronting individuals afflicted by rare diseases, we amalgamate the proficiencies and assets of Addmedica a...
    THERAVIA stands as a premier global pharmaceutical entity focusing on rare or overlooked diseases. Arising from the merger of Addmedica and CTRS, our commitment lies in tackling the unaddressed medical requirements of patients grappling with these complex conditions. Possessing an intimate grasp of the distinct hurdles confronting individuals afflicted by rare diseases, we amalgamate the proficiencies and assets of Addmedica and CTRS to trailblaze innovative treatments. Our objective is to effectuate substantial change in patients' lives, providing them with optimism and an enhanced standard of living.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TheraviaFrance Flag
    Country
    Country
    France
    Address
    Address
    16 rue Montrosier 92200 Neuilly-sur-Seine
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://theravia.com/
    Linkedin
    Linkedin
    https://fr.linkedin.com/company/theraviapharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Norgine Completes Acquisition of Theravia
    Norgine Completes Acquisition of Theravia

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-completes-acquisition-of-theravia-302529332.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share
    Norgine's TGA registration of IfinwiI for high-risk neuroblastoma
    Norgine's TGA registration of IfinwiI for high-risk neuroblastoma

    17 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-welcomes-tga-registration-in-australia-of-ifinwil-eflornithine-for-adults-and-children-diagnosed-with-high-risk-neuroblastoma-hrnb1-302430883.html

    PR NEWSWIRE
    17 Apr 2025
    Share Share
    Norgine acquires Theravia to boost rare disease portfolio
    Norgine acquires Theravia to boost rare disease portfolio

    15 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/norgine-strengthens-rare-disease-portfolio-with-acquisition-of-theravia-302427963.html

    PR NEWSWIRE
    15 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search